Speciality Medicines IPO
Open SmeCurrent GMP
₹0 (0.00%)
Price Band
₹ 117 – 124
Lot Size
1000
Issue Size
₹29 Cr
Minimum Investment
₹248000 (2000 Shares)
Listing Date
30 March 2026
Subscription
2.23x
About the Company
Incorporated in 2021, Speciality Medicines Limited operates in the marketing and distribution of specialty pharmaceutical formulations. The company focuses on high-value oral and injectable medicines used in the treatment of complex and chronic health conditions.
Its product portfolio includes a diverse range of finished formulations available in multiple dosage forms such as tablets, capsules, creams, syrups, eye drops, gels, infusions, inhalers, injections, nasal sprays, ointments, ophthalmic solutions, oral solutions, sachets, and suspensions.
The company follows a dual business model:
- Contract Manufacturing: Manufacturing finished pharmaceutical formulations for international markets.
- Marketing and Distribution: Sourcing, marketing, and distributing specialty pharmaceutical products across domestic and global markets.
Speciality Medicines Limited has established an expanding international presence, with product registrations (approved and under process) in countries including Jordan, Ethiopia, Uganda, Peru, and Namibia. The company has built a strong distribution network spanning over 20 states in India and more than 35 countries worldwide.
As of March 31, 2025, the company had 1 product registered overseas and 60 products under registration across five countries, contributing to its revenue pipeline.
As of August 31, 2025, the company employed 18 permanent staff across various functional departments.
Promoters
- Parth B Goyani
- Goyani Sumit Babubhai
Promoters Holding
Holding Pre Issue
59.67%
Holding Post Issue
0.00%
Objects of the Issue
The Company Speciality Medicines IPO proposes to utilise the Net Proceeds from the Issue towards the following objects.
- Setting up of Research and Development (R&D) Center
- Product registration in the international markets
- Repayment/ prepayment, in full or part, of certain borrowings availed by our Company
- To Meet Working Capital Requirements
- General Corporate Purposes
Address / Contact Info
Speciality Medicines Ltd.
913, One World West, S. No. 396, FP 119,
Village- Vejalpur, Ahmadabad City,
Ahmedabad, Gujarat, India,
Ahmedabad, Gujarat, 380051
Phone: +91 22 4604 5344
Email: investors.grievances@specialitymedicine.com
Website: http://www.specialitymedicine.com/
IPO Snapshot
IPO Timeline (Tentative)
IPO Open Date
Friday, 20 March 2026
IPO Close Date
Tuesday, 24 March 2026
Basis of Allotment
Wednesday, 25 March 2026
Initiation of Refunds
Friday, 27 March 2026
Credit of Shares to Demat
Friday, 27 March 2026
Listing Date
Monday, 30 March 2026 — NSE & BSE
Important Dates
Open Date
20 March 2026
Close Date
24 March 2026
Basis Of Allotment
25 March 2026
Listing Date
30 March 2026
Financial Performance (₹ in Crores)
| Particular | 31 Oct 2025 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Assets | 45.57 | 39.98 | 22.68 |
| Revenue | 36.93 | 58.54 | 27.66 |
| Profit After Tax | 6.06 | 8.61 | 2.93 |
| Net Worth | 36.47 | 30.42 | 15.06 |
| Reserve & Surplus | 30.04 | 23.98 | 9.95 |
| Total Borrowings | 4.81 | 5.05 | 2.86 |
EPS Pre
13.38%
EPS Post
11.82%
P/E Pre
9.27
P/E (Post Issue)
10.49x
Company Financial Information
KPI Information (₹ in Crores)
| Particular | Oct 2025 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| ROE % | 18.11 | 37.85 | 27.95 | 42.69 |
| ROCE % | 16.68 | 33.39 | 36.9 | 50.22 |
| Debt / Equity | 0.13 | 0.17 | 0.19 | 0.61 |
| RoNW % | 16.61 | 28.3 | 19.47 | 28.6 |
| PbW | 0 | 0 | 0 | 0 |
| Pat Margin % | 16.49 | 14.77 | 10.66 | 7.32 |
Return Ratio
IPO Reservations
| Category | Shares Offered | Shares Offered % | Max Allotee |
|---|---|---|---|
| Qualified Institutions | 21000 | 0.95 | 0 |
| Non-Institutional | 1089000 | 49.5 | 0 |
| BNII | 726000 | 33 | 0 |
| SNII | 363000 | 16.5 | 0 |
| Retail Investors | 1090000 | 49.55 | 0 |
| Total | 2200000 | 100 | 0 |
Subscription Status ( Tue, 24 Mar 26 01:59 PM)
| Category | Shares Offered | Shares Bid For | Subscription (x) |
|---|---|---|---|
| Qualified Institutions | 21000 | 2021000 | 96.24x |
| Non-Institutional | 1089000 | 2194000 | 2.01x |
| BNII | 726000 | 1963000 | 2.7x |
| SNII | 363000 | 231000 | 0.64x |
| Retail Investors | 1090000 | 922000 | 0.85x |
| Total | 3289000 | 7331000 | 2.23x |
Subscription figures are updated periodically and may change until issue closing. Data reflects bids placed across exchanges.
Peer Comparision
| Company | Face Value | PE Ratio | EPS Basic | EPS Diluted | RoNW | Net Assets |
|---|---|---|---|---|---|---|
| Speciality Medicines Ltd | 10 | 0.00 | 14.10 | 14.10 | 28.42 | 47.26 |
| Remus Pharmaceuticals Ltd | 10 | 10.41 | 65.21 | 65.21 | 15.02 | 434.25 |
| Trident Lifeline Ltd | 10 | 27.00 | 10.22 | 10.22 | 18.23 | 56.05 |
| Mono Pharmacare Ltd | 10 | 7.49 | 1.75 | 1.75 | 9.90 | 17.66 |
Lot Size & Investment Details
| Application | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 2 | 2,000 | 248,000.00 |
| Retail (Max) | 2 | 2,000 | 248,000.00 |
| S-HNI (Min) | 3 | 3,000 | 372,000.00 |
| S-HNI (Max) | 8 | 8,000 | 992,000.00 |
| B-HNI (Min) | 9 | 9,000 | 1,116,000.00 |
Registrar
Skyline Financial Services Private Ltd
02228511022
info@skylinerta.com
https://www.skylinerta.com
Book Running Lead Managers
- Unistone Capital Pvt Ltd
RHP Document
DRHP Document
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
Speciality Medicines IPO is a Book-building IPO worth ₹29 crores. The price band is ₹117 to 124 per share. The IPO opens on Fri, Mar 20, 2026 and closes on Tue, Mar 24, 2026. It will be listed on BSE and NSE. Skyline Financial Services Private Ltd is the registrar.
The Speciality Medicines IPO opens on Fri, Mar 20, 2026 and closes on Tue, Mar 24, 2026
Speciality Medicines IPO Price Band is ₹117 to 124.
Speciality Medicines IPO lot size is 1000, and the minimum amount required for application is ₹248000.
The minimum investment for Speciality Medicines IPO is approximately ₹248000 based on the upper price band.
To apply for the Speciality Medicines IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of Tue, Mar 24, 2026. After submission, funds are blocked until the basis of allotment of Speciality Medicines IPO is finalised.
Speciality Medicines IPO issue size is ₹29 crores.
Speciality Medicines IPO allotment date is Sat, Jun 27, 2026.
The registrar for Speciality Medicines IPO is Skyline Financial Services Private Ltd. Investors can go to Skyline Financial Services Private Ltd website for IPO allotment status, refund processing, and other queries related to Speciality Medicines IPO through their official website or helpline.